Announcements Trials
Browse Landscape

Phase

Phase NA 2

Status

Terminated 3Completed 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Vasculitis 1Stomach Neoplasms 1Osteomyelitis 1Heart Diseases 1Fever of Unknown Origin 1Dementia 1

Interventions

Cyclophosphamide 641Bevacizumab 552Paclitaxel 534Carboplatin 533Cisplatin 480pembrolizumab 454Gemcitabine 422Docetaxel 415Rituximab 386Radiotherapy 373Dexamethasone 351Doxorubicin 330Nivolumab 308Fluorouracil 286Capecitabine 260Etoposide 245Prednisone 244Oxaliplatin 242Erlotinib Hydrochloride 242Cytarabine 233Lenalidomide 232Trastuzumab 226Pemetrexed 220Vincristine 212fludarabine phosphate 208Leucovorin 208Cetuximab 208Filgrastim 204Bortezomib 193Methotrexate 183

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Completed × Has results × Tomography, Emission-Computed × Clear all
NCT01939275 2025-02-28

64Cu DOTA-Trastuzumab PET/CT in Studying Patients With Gastric Cancer

City of Hope Medical Center

Phase NA Completed
8 enrolled 4 charts
Gastrointestinal

Stomach Neoplasms

NCT02084147 2019-10-29

PET-MRI in Diagnosing Patients With Cancer, Cardiac Diseases, or Neurologic Diseases

Case Comprehensive Cancer Center

Phase NA Completed
72 enrolled 5 charts

Dementia, Fever of Unknown Origin, Heart Diseases, Osteomyelitis, Vasculitis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡